| pubmed-article:10071001 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C0035173 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C0005821 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C0034155 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C0040207 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C0449259 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C0678226 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C2348535 | lld:lifeskim |
| pubmed-article:10071001 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:10071001 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:10071001 | pubmed:dateCreated | 1999-3-11 | lld:pubmed |
| pubmed-article:10071001 | pubmed:abstractText | Thrombotic thrombocytopenic purpura (TTP) is a rare and often fatal disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, mental status changes, and renal dysfunction. Ticlopidine hydrochloride is 1 of several drugs that have been associated with this disorder and is currently used routinely in the approximately 500000 patients per year in the United States who undergo a percutaneous coronary intervention involving a stent. | lld:pubmed |
| pubmed-article:10071001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10071001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10071001 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10071001 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10071001 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10071001 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10071001 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10071001 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10071001 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:10071001 | pubmed:issn | 0098-7484 | lld:pubmed |
| pubmed-article:10071001 | pubmed:author | pubmed-author:TopolE JEJ | lld:pubmed |
| pubmed-article:10071001 | pubmed:author | pubmed-author:SteinhublS... | lld:pubmed |
| pubmed-article:10071001 | pubmed:author | pubmed-author:DyeD EDE | lld:pubmed |
| pubmed-article:10071001 | pubmed:author | pubmed-author:FoodyJ MJM | lld:pubmed |
| pubmed-article:10071001 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10071001 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:10071001 | pubmed:volume | 281 | lld:pubmed |
| pubmed-article:10071001 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10071001 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10071001 | pubmed:pagination | 806-10 | lld:pubmed |
| pubmed-article:10071001 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:meshHeading | pubmed-meshheading:10071001... | lld:pubmed |
| pubmed-article:10071001 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10071001 | pubmed:articleTitle | Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. | lld:pubmed |
| pubmed-article:10071001 | pubmed:affiliation | Department of Cardiology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Tex 78236-5300, USA. steinhubl@whmc.af.mil | lld:pubmed |
| pubmed-article:10071001 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10071001 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10071001 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10071001 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10071001 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10071001 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10071001 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10071001 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10071001 | lld:pubmed |
